COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02893241
Recruitment Status : Completed
First Posted : September 8, 2016
Last Update Posted : March 20, 2018
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Ratiopharm GmbH )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2017
Actual Study Completion Date : December 31, 2017